Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Atropine Sulphate Injection
Atropine sulfate 0.06%w/v
Solution for injection
Max Health Limited
Macarthys Laboratories Limited t/a Martindale Pharmaceuticals, London, United Kingdom
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Xolair
Omalizumab 150mg/mL
Solution for injection
Novartis New Zealand Limited
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
|
|
Product:
Active Ingredient:
Dosage Form:
New Zealand Sponsor:
Manufacturer:
|
Xolair
Omalizumab 75mg/0.5mL
Solution for injection
Novartis New Zealand Limited
Vetter Pharma-Fertigung GmbH & Co KG, Langenargen, Germany
|
Dated this 3rd day of August 2017.
ALISON COSSAR, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).
Gazette.govt.nz